After completing this activity, pharmacists should be able to:
- describe the difference between small and large molecule drugs;
- describe the biologic drugs used in Australia;
- describe biosimilars and their use in Australia.
The 2016 Competency Standards addressed by this activity include: 1.3, 1.5, 3.1, 3.2, 3.3, 3.5
Accreditation number: A2006AJP1 Accreditation expires: 01/06/2021
This activity has been accredited for 1.0 hour of Group One CPD (or 1.0 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1.0 hours of Group Two CPD (or 2.0 CPD credits) upon successful completion of the associated assessment activity.